Neighborhood disadvantage and cardiovascular health in early adolescents in the United States
American Journal of Preventive Cardiology · 2026-12 · 30 · 101749
DOI: 10.1016/j.ajpc.2026.101749 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-12. Verfasst von Christiane K Helmer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Adolescent & Young Adult Medicine, Department of Pediatrics, University of California, San Francisco, CA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Doris Duke Charitable Foundation Inc, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Introduction
Adolescence is a critical period during which exposures to cardiovascular disease risk factors and related pathophysiologic changes begin. Yet neighborhood-level factors shaping cardiovascular health from adolescence onward remain understudied. The American Heart Association's Life's Essential 8 (LE8) is a composite cardiovascular health score, encompassing diet, physical activity, body mass index, blood pressure, and other factors. Area Deprivation Index (ADI), Social Vulnerability Index (SVI), and Childhood Opportunity Index (COI) estimate neighborhood disadvantage. This study examines associations between neighborhood disadvantage and LE8 cardiovascular risk factors in early adolescents.
Methods
We analyzed data from the Adolescent Brain Cognitive Development (ABCD) Study, including 8,160 early adolescents with behavioral subcomponent scores and 1,125 with overall LE8 and health factors subcomponent scores. Neighborhood disadvantage indices (ADI, SVI, COI) were derived from geospatial data. Multivariable linear regression models assessed associations between ADI, SVI, and COI at baseline (2016-2018) and LE8 scores at Year 2 (2018-2020) and Year 3 (2019-2021), adjusted for age, sex, and race/ethnicity.
Results
Higher neighborhood disadvantage was associated with lower (less healthy) LE8 cardiovascular health scores in early adolescents, driven mainly by behavioral factors. Overall LE8 scores were 9.45 points lower for the most deprived ADI quintile (95% CI: -11.86, -7.05; p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Adolescent & Young Adult Medicine, Department of Pediatrics, University of California, San Francisco, CA, USA.
- Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, USA.
- Department of Management, Policy and Community Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
- Center for Health Sciences, SRI International, Menlo Park, CA, USA.
Förderung
- Doris Duke Charitable Foundation Inc
- National Heart Lung and Blood Institute
Zitieren
APA
Helmer, C. K., Veira, O., Dooley, E. E., Magid, H. S. A., Testa, A., Gabriel, K. P., Baker, F. C., Gooding, H. C., & Nagata, J. M. (2026). Neighborhood disadvantage and cardiovascular health in early adolescents in the United States. American Journal of Preventive Cardiology, 30, 101749. https://doi.org/10.1016/j.ajpc.2026.101749
Vancouver
Helmer CK, Veira O, Dooley EE, Magid HSA, Testa A, Gabriel KP, et al. Neighborhood disadvantage and cardiovascular health in early adolescents in the United States. American Journal of Preventive Cardiology. 2026;30:101749. doi:10.1016/j.ajpc.2026.101749
BibTeX
@article{Helmer2026,
author = {Helmer, Christiane K and Veira, Olivia and Dooley, Erin E and Magid, Hoda S Abdel and Testa, Alexander and Gabriel, Kelley Pettee and Baker, Fiona C and Gooding, Holly C and Nagata, Jason M},
title = {Neighborhood disadvantage and cardiovascular health in early adolescents in the United States},
journal = {American Journal of Preventive Cardiology},
year = {2026},
volume = {30},
pages = {101749},
doi = {10.1016/j.ajpc.2026.101749}
}
EUVIMED